Back to Search
Start Over
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study
- Source :
- Collaboration, G B O D C & Ofori-Asenso, R 2019, ' Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study ', JAMA Oncology, vol. 12, pp. 1749-1768 . https://doi.org/10.1001/jamaoncol.2019.2996, JAMA Oncology, REDICUC-Repositorio CUC, Corporación Universidad de la Costa, instacron:Corporación Universidad de la Costa, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, r-FISABIO: Repositorio Institucional de Producción Científica, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, r-FISABIO. Repositorio Institucional de Producción Científica, JAMA Oncol, 2019, ' Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 : A Systematic Analysis for the Global Burden of Disease Study ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2019.2996, JAMA oncology, 5(12), 1749-1768. AMER MEDICAL ASSOC, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
- Publication Year :
- 2019
-
Abstract
- Importance: Cancer and other noncommunicable diseases (NCDs) are now widely recognized as a threat to global development. The latest United Nations high-level meeting on NCDs reaffirmed this observation and also highlighted the slow progress in meeting the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases and the third Sustainable Development Goal. Lack of situational analyses, priority setting, and budgeting have been identified as major obstacles in achieving these goals. All of these have in common that they require information on the local cancer epidemiology. The Global Burden of Disease (GBD) study is uniquely poised to provide these crucial data. Objective: To describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning. Evidence Review: We used the GBD study estimation methods to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-Adjusted life-years (DALYs). Results are presented at the national level as well as by Socio-demographic Index (SDI), a composite indicator of income, educational attainment, and total fertility rate. We also analyzed the influence of the epidemiological vs the demographic transition on cancer incidence. Findings: In 2017, there were 24.5 million incident cancer cases worldwide (16.8 million without nonmelanoma skin cancer [NMSC]) and 9.6 million cancer deaths. The majority of cancer DALYs came from years of life lost (97%), and only 3% came from years lived with disability. The odds of developing cancer were the lowest in the low SDI quintile (1 in 7) and the highest in the high SDI quintile (1 in 2) for both sexes. In 2017, the most common incident cancers in men were NMSC (4.3 million incident cases); tracheal, bronchus, and lung (TBL) cancer (1.5 million incident cases); and prostate cancer (1.3 million incident cases). The most common causes of cancer deaths and DALYs for men were TBL cancer (1.3 million deaths and 28.4 million DALYs), liver cancer (572000 deaths and 15.2 million DALYs), and stomach cancer (542000 deaths and 12.2 million DALYs). For women in 2017, the most common incident cancers were NMSC (3.3 million incident cases), breast cancer (1.9 million incident cases), and colorectal cancer (819000 incident cases). The leading causes of cancer deaths and DALYs for women were breast cancer (601000 deaths and 17.4 million DALYs), TBL cancer (596000 deaths and 12.6 million DALYs), and colorectal cancer (414000 deaths and 8.3 million DALYs). Conclusions and Relevance: The national epidemiological profiles of cancer burden in the GBD study show large heterogeneities, which are a reflection of different exposures to risk factors, economic settings, lifestyles, and access to care and screening. The GBD study can be used by policy makers and other stakeholders to develop and improve national and local cancer control in order to achieve the global targets and improve equity in cancer care. © 2019 American Medical Association. All rights reserved.
- Subjects :
- Cancer Research
age distribution
cancer incidence
Colorectal cancer
GBD, DALY
cancer risk
Global Health
Global Burden of Disease
disease burden
cause of death
trachea cancer
0302 clinical medicine
systematic review
Neoplasms
quality adjusted life year
11. Sustainability
Epidemiology
cancer mortality
030212 general & internal medicine
years of life lost
Stomach cancer
fertility
disabled person
stomach cancer
disability-adjusted life year
nonhodgkin lymphoma
Incidence
1. No poverty
prostate cancer
3. Good health
income
Oncology
risk factor
030220 oncology & carcinogenesis
bladder cancer
Quality-Adjusted Life Years
medicine.medical_specialty
sex difference
3122 Cancers
colorectal cancer
bronchus cancer
Article
educational status
Causes of cancer
liver cancer
03 medical and health sciences
Breast cancer
breast cancer
Environmental health
geographic distribution
medicine
Humans
Disabled Persons
human
business.industry
Correction
Cancer
non melanoma skin cancer
medicine.disease
years lived with disability
lung cancer
Years of potential life lost
Skin cancer
global disease burden
business
neoplasm
RC
uterine cervix cancer
Subjects
Details
- Language :
- English
- ISSN :
- 23742445 and 23742437
- Database :
- OpenAIRE
- Journal :
- Collaboration, G B O D C & Ofori-Asenso, R 2019, ' Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study ', JAMA Oncology, vol. 12, pp. 1749-1768 . https://doi.org/10.1001/jamaoncol.2019.2996, JAMA Oncology, REDICUC-Repositorio CUC, Corporación Universidad de la Costa, instacron:Corporación Universidad de la Costa, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu, r-FISABIO: Repositorio Institucional de Producción Científica, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, r-FISABIO. Repositorio Institucional de Producción Científica, JAMA Oncol, 2019, ' Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 : A Systematic Analysis for the Global Burden of Disease Study ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2019.2996, JAMA oncology, 5(12), 1749-1768. AMER MEDICAL ASSOC, r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
- Accession number :
- edsair.doi.dedup.....3d9cab3161358a0749b151676ab729be